Reading a Blend Certificate: What a Multi-Peptide COA Must Show

Research-use-only context. This article summarizes published third-party scientific literature and laboratory practice. It is not medical advice, not a therapeutic or performance claim, and not a usage guide. US Prime Peptides products are supplied strictly for in vitro laboratory research and are not for human or veterinary use.

A certificate of analysis for a peptide blend has to do everything a single-peptide certificate does, once for every component, and then prove that the components are present in the stated ratio. This article walks through what each line of a blend certificate must show, where blend analytics go wrong, and how to read the certificates for three blends US Prime carries: Wolverine, GLOW and KLOW.

The short answer: one certificate, N identities, N contents, one ratio

A valid blend certificate reports, for each component, an identity result with an observed mass, a purity result from a chromatographic method that resolves that component from the others, and a measured content, and then states the found ratio against the label ratio. Lot-level tests such as endotoxin, sterility and heavy metals are reported once for the vial. A certificate that gives a single purity percentage, a single "identity confirmed" line, or a total mass with no per-component breakdown has not characterized the blend.

The reason is the framework every analytical certificate is built on. USP General Chapter <1225>, following the ICH definition, defines specificity as the ability to assess the analyte unequivocally in the presence of components that may be expected to be present. In a blend, the other peptides are precisely the components expected to be present, so a method that was validated for one peptide alone has not demonstrated specificity for the mixture. ICH Q2(R2), adopted by the FDA as guidance in March 2024, carries the same requirement into current practice. The general guide to reading a certificate covers the single-peptide case; everything below is what changes when there is more than one.

Identity: one observed mass per component

The identity section of a blend certificate must list the expected and observed mass for every peptide separately. Mass spectrometry handles mixtures well when the components differ in mass, which is the case for every blend discussed here, but the certificate has to show that the lab looked for each one. For Wolverine, that means a signal consistent with BPC-157 (monoisotopic mass about 1,418.7 Da, often seen as the doubly charged ion near m/z 710) and a signal consistent with thymosin beta-4 (about 4,963 Da monoisotopic; the 1981 sequencing paper computed 4,982; observed across several charge states). The TB-500 line deserves particular attention: a 2012 Drug Testing and Analysis study by Esposito and colleagues found that a product sold as TB-500 contained Ac-LKKTETQ, the acetylated 17-23 fragment of thymosin beta-4 at about 889 Da, rather than the full-length peptide. A blend certificate that reports an observed mass near 889 for the TB-500 component is describing a different molecule from one that reports a mass near 4,963, and both are "TB-500" on the label.

For GLOW and KLOW, the GHK-Cu line is the unusual one. The copper complex can dissociate under acidic electrospray conditions, so the observed mass may correspond to the free tripeptide GHK (about 340.2 Da) rather than the complex (about 403.7 Da with copper). A careful certificate states which species was observed and, ideally, confirms copper by ICP-MS as part of the elemental panel, since the metal content is also the evidence that the component is GHK-Cu rather than plain GHK. KPV, at about 342.4 Da, is close in mass to free GHK and must be reported as its own line with its own retention time so the two tripeptides are not conflated.

Purity: resolution, co-elution and the chromatogram you should expect

Purity by HPLC is where blend certificates most often fail quietly. A chromatographic purity value is only meaningful if the method separates each component from the others and from their impurities, and the measure of that separation is resolution. USP <621> defines resolution as R = 2(t_R2 − t_R1)/(W₁ + W₂), the difference in retention times divided by the average baseline peak width, and regards direct measurement of resolution as more reliable than plate count for judging a separation. Two peaks with R near 1.5 are baseline-resolved; below that they overlap, and an overlapping impurity under a main peak inflates the apparent purity of that component.

What a blend chromatogram should look like depends on the components. In Wolverine, BPC-157 and thymosin beta-4 differ substantially in size and hydrophobicity and separate easily on a standard reverse-phase gradient; the certificate should show two well-separated main peaks, each with its own area-percent purity, and a stated resolution between them. In GLOW and KLOW the small, polar tripeptides elute early, close to the void volume on a C18 column, and close to each other. A 2017 Talanta study by Janvier and colleagues addressed exactly this class of problem for polar peptides by moving to hydrophilic-interaction chromatography after screening several HILIC columns for resolution and symmetry, and validating the result against the ISO 17025 framework. A lab certifying KLOW may therefore need two chromatographic conditions, or a diode-array peak-purity check of the kind described by Jain and colleagues in a 2009 stability-indicating method, to show that the GHK-Cu and KPV peaks are each a single species. The chromatogram reading guide covers shoulders, tailing and gradient artifacts.

Content and ratio: the lines that prove the label masses

Purity tells you how clean each component is; content tells you how much of each is in the vial, and only content can verify the label ratio. For a blend, the content line should give a mass or percentage for each component and a found ratio. The methods that do this credibly are those that do not depend on resolving the peaks: amino acid analysis after acid hydrolysis, which Woolfitt and colleagues implemented with isotope-dilution LC-MS/MS in a 2009 Analytical Chemistry paper, and quantitative LC-MS against a reference standard for each peptide. Amino acid analysis has a limitation in blends: it measures total residues, so it reports the combined peptide content and cannot by itself apportion it between components with overlapping compositions. The practical approach is to combine a total net peptide content from nitrogen or amino acid analysis with the per-component area ratios from a resolved chromatogram, and the certificate should say that is what was done.

Counter-ions complicate ratios. Each component carries its own acetate or trifluoroacetate load, and a 1998 Journal of Chromatography A method by Hettiarachchi and Ridge showed that both can be quantified in synthetic peptides by capillary electrophoresis. A 2025 consensus paper by Erckes and colleagues in Pharmaceuticals argues that TFA content should be reported routinely because it varies between lots. Bachem's technical FAQ defines net peptide content as the peptidic fraction relative to counter-ions and water, and GenScript's AccuPep note expresses the mass balance as target peptide plus peptidic impurities plus counter-ion plus water equal to 100 percent. In GLOW, a 50 mg GHK-Cu label mass with a net peptide content of 75 percent and a 10 mg BPC-157 label mass with a net content of 85 percent would give a real peptide ratio of roughly 4.4:1, not 5:1. A certificate that reports net content per component lets you compute that; one that reports a single net content for the whole vial does not. The net peptide content guide explains why the two numbers diverge.

Worked example: reading a KLOW certificate top to bottom

Take KLOW (GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg, KPV 10 mg) as the hardest case. The header should carry the product name, the lot number matching the vial, the test and issue dates, and the name of the independent laboratory. The identity block should contain four rows, each with an expected and observed mass: GHK or GHK-Cu with a note on which species was observed, BPC-157 near 1,419, TB-500 with a mass that settles whether it is the 43-residue peptide or the 889 Da fragment, and KPV near 342. The purity block should assign each component to a retention time and give an area percent for each, with a statement of resolution between neighbors; the two tripeptides are the pair to scrutinize. The content block should report net peptide content and a found mass or ratio for each of the four. The elemental panel should report copper as a positive finding consistent with the GHK-Cu label mass. GLOW reads the same way with three rows, and Wolverine with two; US Prime posts the lot-matched certificate on each product page so these blocks can be checked before purchase.

Red flags specific to blend certificates

Several patterns indicate that a blend was certified as if it were a single peptide. A single purity figure with no per-component breakdown is the most common. An identity line that says "conforms" without observed masses is the second. A chromatogram with fewer main peaks than there are components, or with one peak carrying most of the area for a blend whose components are equal by mass, means either the components did not separate or one of them is missing. A content line expressed only as a total mass cannot verify the ratio. The falsified-product literature shows why these gaps matter: a 2018 Talanta study by Janvier and colleagues found that peptide products bought from illegal online sellers varied widely in amount per unit and in purity, and a certificate that cannot distinguish components cannot catch that variation in a mixture. The guide to verifying a lab report covers the step after reading: confirming with the issuing laboratory that the document is genuine.

Frequently Asked Questions

What should a peptide blend COA include?

For each component: an identity result with an observed mass, a purity value from a chromatographic method that resolves it from the other components, and a measured content. Then a found ratio against the label ratio, plus the lot-level endotoxin, sterility and heavy-metal results. A single purity number for the whole vial does not characterize a blend.

Why is HPLC purity harder to measure for a blend than for a single peptide?

Because purity by area percent only works when each peak is one species. In a blend the components can co-elute with each other or with each other's impurities, especially small polar peptides like GHK-Cu and KPV that elute early on reverse-phase columns. The certificate should state the resolution between neighboring peaks or show peak-purity evidence.

How do I check the ratio on a blend certificate?

Look for a content result per component, not a total. Combine the per-component net peptide content with the label masses to get the real peptide ratio; counter-ion and water fractions differ between components, so a 5:1 label ratio can be a 4.4:1 peptide ratio. If the certificate reports only one net content for the vial, the ratio has not been verified.

What does the TB-500 line on a Wolverine certificate need to show?

An observed mass that identifies which molecule is present. Full-length thymosin beta-4 has a monoisotopic mass near 4,963 Da; the acetylated 17-23 fragment that has been found in some TB-500 products is about 889 Da. Both are sold under the same name, and only the mass on the certificate distinguishes them.

Citations

1. Esposito S, Deventer K, Goeman J, Van Eenoo P. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. Drug Test Anal. 2012;4(9):733-738. PMID 22962027
2. Janvier S, De Sutter E, Wynendaele E, et al. Analysis of illegal peptide drugs via HILIC-DAD-MS. Talanta. 2017;174:562-571. PMID 28738623
3. Jain R, Wu Z, Tucker IG. A stability-indicating HPLC assay with diode array detection for the determination of a benzylpenicillin prodrug in aqueous solutions. J Pharm Biomed Anal. 2009;50(5):841-846. PMID 19640667
4. Woolfitt AR, Solano MI, Williams TL, et al. Amino acid analysis of peptides using isobaric-tagged isotope dilution LC-MS/MS. Anal Chem. 2009;81(10):3979-3985. PMID 19364092
5. Hettiarachchi K, Ridge S. Capillary electrophoretic determination of acetic acid and trifluoroacetic acid in synthetic peptide samples. J Chromatogr A. 1998;817(1-2):153-161. PMID 9764489
6. Erckes V, Streuli A, Chamera Rendueles L, et al. Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides and Its Influence on Membrane Permeation. Pharmaceuticals (Basel). 2025;18(8). PMID 40872554
7. Janvier S, Cheyns K, Canfyn M, et al. Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market. Talanta. 2018;188:795-807. PMID 30029448
8. Vanhee C, Janvier S, Desmedt B, et al. Analysis of illegal peptide biopharmaceuticals frequently encountered by controlling agencies. Talanta. 2015;142:1-10. PMID 26003685
9. United States Pharmacopeia. General Chapter <621> Chromatography (USP 35-NF 30 text). USP <621>
10. United States Pharmacopeia. General Chapter <1225> Validation of Compendial Procedures (USP 35-NF 30 text). USP <1225>
11. U.S. FDA. Q2(R2) Validation of Analytical Procedures: Guidance for Industry. March 2024. fda.gov
12. Bachem. What does net peptide content mean? Technical FAQ. bachem.com
13. GenScript. AccuPep+ QC: peptide quality analysis (purity, net peptide content, counter-ion, water, mass balance). genscript.com

This article is for laboratory research reference only. US Prime Peptides products are supplied strictly for in vitro research. Not for human consumption.

Compliance Notice: US Prime Peptides products are supplied strictly for laboratory and academic research purposes only. They are not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any disease. All content on this page is educational in nature and does not constitute medical advice or product claims. Researchers are responsible for handling these compounds in accordance with their institution’s safety protocols and applicable laws.